MoonLake Immunotherapeutics Class A stock price

문레이크 이뮤노테라퓨틱스NASDAQ:MLTX · Nasdaq · Healthcare · sector #17
$10.95-3.78%
2026-10-06 close
Loading chart…

Today's signals · No active technical signal.

Signal details →

MoonLake Immunotherapeutics Class A last closed at $10.95 (-3.78%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -3.1×. Its overall grade ranks 552 of 740 stocks in Healthcare.

About this company

MoonLake Immunotherapeutics Class A last closed at $10.95 (-3.78%) on 2026-10-06. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall C · 552/740

Valuation grade B+

Details →

Related stocks

  • AbbVieCompetitor

    염증성 질환 치료제 시장의 대형 경쟁사

  • 면역·염증성 자가면역 치료제 분야의 글로벌 경쟁사

  • Eli LillyCompetitor

    염증성 질환 및 면역질환 치료제 개발 경쟁사

Details →
About MoonLake Immunotherapeutics Class A
What technical signals does MoonLake Immunotherapeutics Class A (MLTX) have?
MoonLake Immunotherapeutics Class A current technical signals: no active technical signal.
Is MoonLake Immunotherapeutics Class A a cup-and-handle pattern?
No. MoonLake Immunotherapeutics Class A has no valid Cup signal right now.
What published figures are available for MoonLake Immunotherapeutics Class A?
Market cap: $954.28M. Trailing 12 months PER: -3.1×. Latest quarter PBR: 1.89×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about MoonLake Immunotherapeutics Class A, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

MoonLake Immunotherapeutics Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy